- Home
- FHTX vs DIN Comparison
FHTX vs DIN Comparison
Compare FHTX & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FHTX | DIN |
|---|---|---|
| Founded | 2015 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.9M | 399.8M |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | FHTX | DIN |
|---|---|---|
| Price | $6.22 | $33.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 7 |
| Target Price | $11.50 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 299.4K | 234.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.78% |
| EPS Growth | ★ 25.32 | N/A |
| EPS | N/A | ★ 0.92 |
| Revenue | $30,909,000.00 | ★ $879,300,000.00 |
| Revenue This Year | $8.89 | $3.61 |
| Revenue Next Year | $20.13 | $0.64 |
| P/E Ratio | ★ N/A | $38.27 |
| Revenue Growth | ★ 36.75 | 8.25 |
| 52 Week Low | $3.27 | $22.47 |
| 52 Week High | $7.61 | $39.68 |
Technical Indicators
Market Signals| Indicator | FHTX | DIN |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 42.85 |
| Support Level | $4.21 | $32.85 |
| Resistance Level | $6.76 | $36.50 |
| Average True Range (ATR) | 0.53 | 1.43 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 12.95 | 25.11 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.